Biohaven (BHVN) Total Non-Current Liabilities (2021 - 2026)

Biohaven has disclosed Total Non-Current Liabilities across 6 years of filings, most recently posting $332.3 million for Q1 2026.

• Total Non-Current Liabilities for Q1 2026 came in at $332.3 million, up 199.06% year-over-year; the trailing twelve-month figure through Mar 2026 was $332.3 million (up 199.06% YoY), and the FY2025 annual result was $394.8 million, up 111.11% from the prior year.
• Total Non-Current Liabilities came in at $332.3 million for Q1 2026 at Biohaven, down from $394.8 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $394.8 million in Q4 2025 to a low of $28.4 million in Q3 2022.
• The 5-year median for Total Non-Current Liabilities is $143.8 million (2023), against an average of $161.6 million.
• Peak annual rise in Total Non-Current Liabilities reached 218.14% in 2023, while the deepest fall reached 31.19% in 2023.
• Biohaven's Total Non-Current Liabilities stood at $120.6 million in 2022, then sank by 31.19% to $83.0 million in 2023, then surged by 125.33% to $187.0 million in 2024, then surged by 111.11% to $394.8 million in 2025, then fell by 15.82% to $332.3 million in 2026.
• The last three Total Non-Current Liabilities figures came in at $332.3 million (Q1 2026), $394.8 million (Q4 2025), and $158.0 million (Q3 2025), per Business Quant data.